{
  "url": "https://openlegislation.uk/human-medicines-amendment-regulations-2019/regulation-18",
  "json_url": "https://openlegislation.uk/human-medicines-amendment-regulations-2019/regulation-18.json",
  "legislation": "uksi/2019/62",
  "legislation_title": "The Human Medicines (Amendment) Regulations 2019",
  "legislation_url": "https://openlegislation.uk/human-medicines-amendment-regulations-2019",
  "path": "regulation/18",
  "kind": "regulation",
  "number": "18",
  "heading": "Amendment of Schedule 17 (exemption for sale, supply or administration by certain persons)",
  "text": "In Schedule 17—\n(a) in the table in Part 2 (exemption from the restriction on supply of prescription only medicines), in item 4a, in the words in column 2, omit “for parenteral administration”; and\n(b) in the table in Part 5 (exemptions from the restrictions in regulations 220 and 221), in item 7a, for the words in column 2 substitute “A medicinal product containing naloxone hydrochloride but no other substance that is classified as a product available only on prescription or as a product available only from a pharmacy.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Part 2 was amended by S.I. 2014/490 and 1878, 2015/1503 and 2016/186."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "Part 5 was amended by S.I. 2015/1503, 2016/186 and 2018/199."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2019/62/regulation/18",
    "retrieved_at": "2026-10-28T22:49:09.308987+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}